Southern Finance and Economics, September 12th - According to Interface News and Fierce Biotech, multinational pharmaceutical company AbbVie has recently sued BeiGene again for plagiarizing the trade secrets of its BTK degrader. BeiGene stated that it has been informed that AbbVie has recently filed a lawsuit against our company, which includes the compound BGB-16673 independently discovered by BeiGene. BeiGene will vigorously defend itself against the allegations made by AbbVie. The company is currently carefully reviewing AbbVie's allegations and will respond appropriately through legal procedures.